Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)

NACompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

September 30, 1991

Study Completion Date

September 30, 1994

Conditions
Coronary Artery Bypass Graft Surgery
Interventions
PROCEDURE

Regulating Mean Arterial Pressure during cardiopulmonary bypass

Patients were randomized to one of two groups. In the first group (Low) the goal was to maintain MAP between 50-60 mm Hg during CPB. In the second group (High), the goal was to maintain MAP between 80-100 mm Hg. In both groups, CPB flow was held constant at 1.6 L/min/M2 (cool) and 2.4 L/min/M2 (warm) and vasoactive drugs (nitroglycerin or phenylephrine) were used to maintain MAP in the desired range. MAP was controlled in this fashion from the onset of CPB through separation from CPB began.

Trial Locations (1)

10065

New York Presbyterian Hospital-Weill Cornell Medical College, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT00248885 - Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG) | Biotech Hunter | Biotech Hunter